Market Overview:
The global immunoassay market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising demand for early diagnosis and treatment, and technological advancements in immunoassay products. The global immunoassay market is segmented by type, application, and region. By type, the market is divided into ELISA, rapid tests, western blotting, ELISPOT assay kits & reagents), Immuno-PCR (real-time PCR), and other technologies (immunofluorescence assay [IFA], chemiluminescence assay [CLA], time-resolved fluorescence resonance energy transfer [TR-FRET]). The ELISA segment accounted for the largest share of the global immunoassay market in 2017 owing to its high accuracy and sensitivity. By application, hospitals accounted for the largest share of the global immunoassay market in 2017 due to rising demand for early diagnosis and treatment of chronic diseases.
Product Definition:
An immunoassay is a laboratory technique that uses antibodies to detect and quantify specific proteins, carbohydrates, or nucleic acids in a sample. Immunoassays are used in a wide variety of applications, including diagnostics, drug development and screening, food safety monitoring, and environmental testing.
ELISA:
ELISA, or enzyme-linked immunosorbent assay is a technique used for detecting the presence of an analyte in biological fluids. It is one of the most commonly employed immunoassay techniques and has been around for more than two decades.
Rapid Tests:
Rapid tests are also known as non-competitive or direct immunoassay tests. These are used to detect the presence of a specific antibody in the blood sample. The test is performed by using a special reagent that helps in detecting and identifying antibodies present in the blood sample. It does not involve RBCs (red blood cells) separation, unlike other conventional techniques such as ELISA (enzyme-linked immunosorbent assay).
Application Insights:
The clinical laboratories segment dominated the global immunoassay market in 2017. This was attributed to factors such as an increase in demand for rapid tests by primary care physicians and a rise in number of hospital-based diagnostic centers. Furthermore, key players have been investing significantly to expand their presence across the globe. For instance, Roche has established new facilities at a global level to manufacture its products that offer high specificity and sensitivity for disease diagnosis.
In June 2018, CSLabs opened a new facility at Pune, India with an investment of USD 120 million to manufacture ImmunoPulse kits for influenza A (H1N1)pdm09 & B viruses under COVID-19 pandemic situation worldwide.
Regional Analysis:
North America dominated the global immunoassay market in 2017. The presence of a large number of biotechnology and pharmaceutical companies, advanced healthcare infrastructure, high disease burden, and rising prevalence of infectious diseases are some factors driving the regional market. In addition, increasing government initiatives to develop novel immunoassays is also expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rapid economic development coupled with improving healthcare facilities in emerging countries such as China and India. Furthermore, an increase in chronic diseases due to unhealthy lifestyles will boost demand for diagnostic tests which will further propel revenue generation during the forecast period. ‰â€˜Immuno-magnetic bead array technology’ was first introduced by CELGENE CORP., USA for diagnosis of MCTD using blood sample from 1990s (Krishna et al.
Growth Factors:
- Increasing incidence of chronic diseases: The global immunoassay market is expected to grow at a CAGR of 7.5% from 2016 to 2021, owing to the increasing incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders. Immunoassays are used for the diagnosis and treatment monitoring of these diseases.
- Technological advancements: The development of novel immunoassay technologies has led to the introduction of new products in the market, which is driving its growth. For instance, in 2015 Abbott Laboratories launched an automated immunoassay analyzer that can detect multiple analytes simultaneously using a single sample preparation step. This reduces assay time and increases throughputs significantly compared with traditional methods that use multiple assay steps and instruments for performing different tests on a single sample specimen.
Scope Of The Report
Report Attributes
Report Details
Report Title
Immunoassay Market Research Report
By Type
ELISA, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, Other Technologies
By Application
Hospitals, Blood Banks, Clinical Laboratories, Research & Academic Laboratories, Other End Users
By Companies
Roche, Abbott Laboratories, Siemens, Danaher, DiaSorin, Sysmex, BioMerieux, Ortho Clinical Diagnostics, QIAGEN, Thermo Fisher, Becton, Dickinson, Bio-Rad Laboratories, Agilent Technologies, Mindray, Perkinelmer, Quidel, Merck, Bio-Techne
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
151
Number of Tables & Figures
106
Customization Available
Yes, the report can be customized as per your need.
Global Immunoassay Market Report Segments:
The global Immunoassay market is segmented on the basis of:
Types
ELISA, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, Other Technologies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Blood Banks, Clinical Laboratories, Research & Academic Laboratories, Other End Users
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Abbott Laboratories
- Siemens
- Danaher
- DiaSorin
- Sysmex
- BioMerieux
- Ortho Clinical Diagnostics
- QIAGEN
- Thermo Fisher
- Becton, Dickinson
- Bio-Rad Laboratories
- Agilent Technologies
- Mindray
- Perkinelmer
- Quidel
- Merck
- Bio-Techne
Highlights of The Immunoassay Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ELISA
- Rapid Tests
- Western Blotting
- ELISPOT
- Immuno-PCR
- Other Technologies
- By Application:
- Hospitals
- Blood Banks
- Clinical Laboratories
- Research & Academic Laboratories
- Other End Users
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immunoassay Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An immunoassay is a laboratory technique that uses antibodies to identify and quantify the presence of specific molecules in a sample.
Some of the key players operating in the immunoassay market are Roche, Abbott Laboratories, Siemens, Danaher, DiaSorin, Sysmex, BioMerieux, Ortho Clinical Diagnostics, QIAGEN, Thermo Fisher, Becton, Dickinson, Bio-Rad Laboratories, Agilent Technologies, Mindray, Perkinelmer, Quidel, Merck, Bio-Techne.
The immunoassay market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Immunoassay Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Immunoassay Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Immunoassay Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Immunoassay Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Immunoassay Market Size & Forecast, 2018-2028
4.5.1 Immunoassay Market Size and Y-o-Y Growth
4.5.2 Immunoassay Market Absolute $ Opportunity
Chapter 5 Global Immunoassay Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Immunoassay Market Size Forecast by Type
5.2.1 ELISA
5.2.2 Rapid Tests
5.2.3 Western Blotting
5.2.4 ELISPOT
5.2.5 Immuno-PCR
5.2.6 Other Technologies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Immunoassay Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Immunoassay Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Blood Banks
6.2.3 Clinical Laboratories
6.2.4 Research & Academic Laboratories
6.2.5 Other End Users
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Immunoassay Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Immunoassay Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Immunoassay Analysis and Forecast
9.1 Introduction
9.2 North America Immunoassay Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Immunoassay Market Size Forecast by Type
9.6.1 ELISA
9.6.2 Rapid Tests
9.6.3 Western Blotting
9.6.4 ELISPOT
9.6.5 Immuno-PCR
9.6.6 Other Technologies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Immunoassay Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Blood Banks
9.10.3 Clinical Laboratories
9.10.4 Research & Academic Laboratories
9.10.5 Other End Users
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Immunoassay Analysis and Forecast
10.1 Introduction
10.2 Europe Immunoassay Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Immunoassay Market Size Forecast by Type
10.6.1 ELISA
10.6.2 Rapid Tests
10.6.3 Western Blotting
10.6.4 ELISPOT
10.6.5 Immuno-PCR
10.6.6 Other Technologies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Immunoassay Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Blood Banks
10.10.3 Clinical Laboratories
10.10.4 Research & Academic Laboratories
10.10.5 Other End Users
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Immunoassay Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Immunoassay Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Immunoassay Market Size Forecast by Type
11.6.1 ELISA
11.6.2 Rapid Tests
11.6.3 Western Blotting
11.6.4 ELISPOT
11.6.5 Immuno-PCR
11.6.6 Other Technologies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Immunoassay Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Blood Banks
11.10.3 Clinical Laboratories
11.10.4 Research & Academic Laboratories
11.10.5 Other End Users
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Immunoassay Analysis and Forecast
12.1 Introduction
12.2 Latin America Immunoassay Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Immunoassay Market Size Forecast by Type
12.6.1 ELISA
12.6.2 Rapid Tests
12.6.3 Western Blotting
12.6.4 ELISPOT
12.6.5 Immuno-PCR
12.6.6 Other Technologies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Immunoassay Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Blood Banks
12.10.3 Clinical Laboratories
12.10.4 Research & Academic Laboratories
12.10.5 Other End Users
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Immunoassay Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Immunoassay Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Immunoassay Market Size Forecast by Type
13.6.1 ELISA
13.6.2 Rapid Tests
13.6.3 Western Blotting
13.6.4 ELISPOT
13.6.5 Immuno-PCR
13.6.6 Other Technologies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Immunoassay Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Blood Banks
13.10.3 Clinical Laboratories
13.10.4 Research & Academic Laboratories
13.10.5 Other End Users
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Immunoassay Market: Competitive Dashboard
14.2 Global Immunoassay Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Abbott Laboratories
14.3.3 Siemens
14.3.4 Danaher
14.3.5 DiaSorin
14.3.6 Sysmex
14.3.7 BioMerieux
14.3.8 Ortho Clinical Diagnostics
14.3.9 QIAGEN
14.3.10 Thermo Fisher
14.3.11 Becton, Dickinson
14.3.12 Bio-Rad Laboratories
14.3.13 Agilent Technologies
14.3.14 Mindray
14.3.15 Perkinelmer
14.3.16 Quidel
14.3.17 Merck
14.3.18 Bio-Techne
